Rigel stockholders approve 2018 Equity Plan amendment adding 5M shares

RIGEL PHARMACEUTICALS INC

Amended 2018 Equity Incentive Plan increases authorized shares by 5,000,000, effective immediately after stockholder approval on May 19, 2022.
Vote on amendment: 72,954,216 for, 47,859,509 against, 1,366,196 abstain, 19,065,889 broker non-votes.
Stockholders elected directors Kamil Ali-Jackson and Jane Wasman to terms expiring at 2025 annual meeting.
Say-on-pay advisory vote approved: 113,344,916 for, 7,265,856 against, 1,569,149 abstain.
Ernst & Young ratified as independent auditor for FY2022: 133,170,094 for, 7,845,051 against, 230,665 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.